{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:23:03Z","timestamp":1792088583484,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003951","name":"Orange","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jbspin.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T01:20:16Z","timestamp":1537406416000},"page":"13-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus"],"prefix":"10.1016","volume":"86","author":[{"given":"Laure","family":"Gossec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Molto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Romand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9borah","family":"Puyraimond-Zemmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Lavielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Beauvais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Senbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9-Marc","family":"Flipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Pouplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Richez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Saraux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"M\u00e9zi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loriane","family":"Gutermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2018.08.006_bib0005","unstructured":"World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization http:\/\/www.who.int\/chp\/knowledge\/publications\/adherence_introduction.pdf?ua=1 [accessed on March 23, 2018]."},{"key":"10.1016\/j.jbspin.2018.08.006_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/rheumatology\/kei223","article-title":"\u02bbCompliance\u02bc is futile but is \u02bbconcordance\u2019 between rheumatology patients and health professionals attainable?","volume":"45","author":"Treharne","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0015","doi-asserted-by":"crossref","first-page":"33751","DOI":"10.1586\/eci.12.23","article-title":"Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature","volume":"8","author":"van den Bemt","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0020","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3899\/jrheum.151212","article-title":"Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review","volume":"43","author":"Curtis","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0025","doi-asserted-by":"crossref","first-page":"51223","DOI":"10.3899\/jrheum.141371","article-title":"The rate of adherence to antiarthritis medications and associated factors among patients with rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"43","author":"Scheiman-Elazary","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0030","doi-asserted-by":"crossref","first-page":"18129","DOI":"10.1093\/rheumatology\/kew247","article-title":"Nonadherence to disease-modifying antirheumatic drugs in the first year after diagnosis: comparing three adherence measures in early arthritis patients","volume":"55","author":"Pasma","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0035","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/MAJ.0000000000000376","article-title":"Assessment of rheumatoid arthritis patients\u2019 adherence to treatment","volume":"349","author":"Gadallah","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0040","doi-asserted-by":"crossref","first-page":"28290","DOI":"10.1097\/MAJ.0b013e3181e8bcb0","article-title":"Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs","volume":"340","author":"Contreras-Y\u00e1\u00f1ez","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0045","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1093\/rheumatology\/keu358","article-title":"Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort","volume":"54","author":"Bluett","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0050","doi-asserted-by":"crossref","first-page":"52130","DOI":"10.1097\/01.mlr.0000163641.86870.af","article-title":"Impact of medication adherence on hospitalization risk and healthcare cost","volume":"43","author":"Sokol","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0055","first-page":"CD012042","article-title":"Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication","volume":"1","author":"Zaugg","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0060","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1007\/s11096-013-9865-x","article-title":"Assessing medication adherence: options to consider","volume":"36","author":"Lehmann","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1345\/aph.1L496","article-title":"Comparison of methods to assess medication adherence and classify nonadherence","volume":"43","author":"Hansen","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0070","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.semarthrit.2012.12.001","article-title":"Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review","volume":"43","author":"Pasma","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0075","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12891-016-1289-z","article-title":"Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study","volume":"17","author":"Voshaar","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0080","doi-asserted-by":"crossref","first-page":"153542","DOI":"10.1007\/s00296-016-3566-4","article-title":"Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?","volume":"36","author":"Wong","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0085","doi-asserted-by":"crossref","first-page":"e56247","DOI":"10.1371\/journal.pone.0056247","article-title":"Comparison between two generic questionnaires to assess satisfaction with medication in chronic diseases","volume":"8","author":"Delestras","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/NOR.0b013e3181e5c2c9","article-title":"Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature","volume":"29","author":"Salt","year":"2010","journal-title":"Orthop Nurs"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jbspin.2016.05.012","article-title":"Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France","volume":"83","author":"Gossec","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/ard.2010.128652","article-title":"Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists","volume":"70","author":"Gossec","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0105","doi-asserted-by":"crossref","first-page":"e000684","DOI":"10.1136\/rmdopen-2018-000684","article-title":"Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review","volume":"4","author":"Lavielle","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4065\/mcp.2010.0575","article-title":"Medication adherence: who cares?","volume":"86","author":"Brown","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2015.12.029","article-title":"Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review","volume":"193","author":"Ho","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0120","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11926-014-0460-5","article-title":"Economics of non-adherence to biologic therapies in rheumatoid arthritis","volume":"16","author":"De Vera","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0125","doi-asserted-by":"crossref","first-page":"e0171070","DOI":"10.1371\/journal.pone.0171070","article-title":"Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?","volume":"12","author":"Pasma","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0130","doi-asserted-by":"crossref","first-page":"e80633","DOI":"10.1371\/journal.pone.0080633","article-title":"Understanding patients\u2019 adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework","volume":"8","author":"Horne","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0135","first-page":"133","article-title":"White coat hypertension: improving the patient-health care practitioner relationship","volume":"8","author":"Cobos","year":"2015","journal-title":"Psychol Res Behav Manag"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0150","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","article-title":"Predictive validity of a medication adherence measure in an outpatient setting","volume":"10","author":"Morisky","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.sapharm.2017.05.008","article-title":"Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: a systematic review and meta-analysis","volume":"14","author":"Readdean","year":"2017","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0160","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/annrheumdis-2012-202322","article-title":"Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)","volume":"72","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0165","doi-asserted-by":"crossref","first-page":"91108","DOI":"10.1007\/s12325-016-0441-3","article-title":"Impact of treatment-related beliefs on medication adherence in immune-mediated inflammatory diseases: results of the Global ALIGN Study","volume":"34","author":"Michetti","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0170","doi-asserted-by":"crossref","first-page":"72430","DOI":"10.3899\/jrheum.150414","article-title":"Why do patients with chronic inflammatory rheumatic diseases discontinue their biologics? An assessment of patients\u2019 adherence using a self-report questionnaire","volume":"43","author":"Betegnie","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0175","first-page":"163545","article-title":"Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis","volume":"8","author":"Zwikker","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12891-016-1254-x","article-title":"Patient's experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis","volume":"17","author":"Curtis","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0185","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/MIB.0b013e3182813482","article-title":"Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease","volume":"19","author":"Greenley","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0190","first-page":"CD007768","article-title":"Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews","author":"Ryan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0195","doi-asserted-by":"crossref","first-page":"17887","DOI":"10.1097\/HJH.0000000000001126","article-title":"Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care","volume":"35","author":"Kulchaitanaroaj","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0200","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.2196\/medinform.4326","article-title":"Health information technology: meaningful use and next steps to improving electronic facilitation of medication adherence","volume":"4","author":"Bosworth","year":"2016","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0205","doi-asserted-by":"crossref","first-page":"e016982","DOI":"10.1136\/bmjopen-2017-016982","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review","volume":"8","author":"Cutler","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0210","doi-asserted-by":"crossref","first-page":"e0191817","DOI":"10.1371\/journal.pone.0191817","article-title":"Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk","volume":"13","author":"Fung","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0215","doi-asserted-by":"crossref","first-page":"e015332","DOI":"10.1136\/bmjopen-2016-015332","article-title":"Barriers and facilitators to medication adherence: a qualitative study with general practitioners","volume":"8","author":"Kvarnstr\u00f6m","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3904\/kjim.2015.383","article-title":"Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception","volume":"33","author":"Suh","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","article-title":"2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations","volume":"74","author":"van der Heijde","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0230","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2014-206593","article-title":"What are the effects of medication adherence interventions in rheumatic diseases: a systematic review","volume":"75","author":"Galo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0235","doi-asserted-by":"crossref","first-page":"e0145076","DOI":"10.1371\/journal.pone.0145076","article-title":"Interventions to improve adherence in patients with immune-mediated inflammatory disorders: a systematic review","volume":"10","author":"Depont","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jbspin.2018.08.006_bib0240","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jclinepi.2018.01.004","article-title":"Assessing risk of bias in studies that evaluate health care interventions: recommendations in the misinformation age","volume":"97","author":"Page","year":"2018","journal-title":"J Clin Epidemiol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18303087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18303087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:24:41Z","timestamp":1761150281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X18303087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1297319X18303087"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.08.006","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}